At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 59 enrolled
Drug / intervention
Personalised carddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect on the Adherence to Glaucoma Eye Drops by Improving Patient Understanding and Using a Tele-reminder System: A Randomized Controlled Clinical Trial
National University Health System, Singapore·interventional·Posted Mar 23, 2020·Updated Mar 23, 2020
In Brief
A Phase 2 clinical trial evaluating Personalised card for Glaucoma. Completed, enrolled 59 participants across 1 site.
Detailed Summary
To determine the improvement in patient adherence to topical ocular hypotensive therapy by introducing a personalised illustrated medication reference chart and tele-reminder.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesSingapore
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
Primary CompletionOct 2019
First PostedMar 2020
TodayJul 2026
First PostedMar 23, 2020
Enrollment StartOct 19, 2018
Primary CompletionOct 19, 2019
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 6.3 years ago
Interventions
Personalised carddevice
An individualised card containing the patient's eye drops regime was printed for the patient after his/consult with the physician to be brought home.